Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lindaven
- Development stage
- Unknown
- Lead developer
- PharmaSGP
- Administration
- Oral
01
Overview
Lindaven is an over-the-counter homeopathic oral liquid developed by PharmaSGP for the treatment of hemorrhoids and varicose veins. It is formulated as a mixture of five active homeopathic ingredients: *Aesculus hippocastanum* Dil. D3, *Collinsonia canadensis* Dil. D3, *Hamamelis virginiana* Dil. D2, *Lycopodium clavatum* Dil. D5, and *Sulfur* Dil. D5. These components work synergistically to address symptoms of venous vascular diseases, such as burning, itching, and weeping associated with hemorrhoids, by reducing inflammation and supporting blood vessel contraction from within.
- Brand names
- Lindaven
- Other names
- Lindaven Mischung
Beyond the preview
Go deeper on Lindaven.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lindaven.